- Home
- SBLK vs IDYA Comparison
SBLK vs IDYA Comparison
Compare SBLK & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBLK
- IDYA
- Stock Information
- Founded
- SBLK 2006
- IDYA 2015
- Country
- SBLK Greece
- IDYA United States
- Employees
- SBLK N/A
- IDYA N/A
- Industry
- SBLK Marine Transportation
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- SBLK Consumer Discretionary
- IDYA Health Care
- Exchange
- SBLK Nasdaq
- IDYA Nasdaq
- Market Cap
- SBLK 2.0B
- IDYA 1.9B
- IPO Year
- SBLK N/A
- IDYA 2019
- Fundamental
- Price
- SBLK $18.53
- IDYA $22.69
- Analyst Decision
- SBLK Strong Buy
- IDYA Buy
- Analyst Count
- SBLK 3
- IDYA 12
- Target Price
- SBLK $22.67
- IDYA $50.82
- AVG Volume (30 Days)
- SBLK 2.0M
- IDYA 1.0M
- Earning Date
- SBLK 08-06-2025
- IDYA 08-05-2025
- Dividend Yield
- SBLK 1.08%
- IDYA N/A
- EPS Growth
- SBLK N/A
- IDYA N/A
- EPS
- SBLK 1.96
- IDYA N/A
- Revenue
- SBLK $1,236,718,000.00
- IDYA $7,000,000.00
- Revenue This Year
- SBLK N/A
- IDYA $101.20
- Revenue Next Year
- SBLK $14.96
- IDYA $286.70
- P/E Ratio
- SBLK $9.17
- IDYA N/A
- Revenue Growth
- SBLK 25.60
- IDYA N/A
- 52 Week Low
- SBLK $12.06
- IDYA $13.45
- 52 Week High
- SBLK $24.51
- IDYA $44.42
- Technical
- Relative Strength Index (RSI)
- SBLK 68.41
- IDYA 59.61
- Support Level
- SBLK $17.27
- IDYA $20.99
- Resistance Level
- SBLK $18.59
- IDYA $23.06
- Average True Range (ATR)
- SBLK 0.51
- IDYA 0.94
- MACD
- SBLK 0.06
- IDYA 0.01
- Stochastic Oscillator
- SBLK 96.60
- IDYA 85.55
About SBLK Star Bulk Carriers Corp.
Star Bulk Carriers Corp provides seaborne transportation solutions in the dry bulk sector. The company owns and operates dry bulk carrier vessels, which are used to transport bulk, such as iron ore, coal, grains, bauxite, fertilizers, and steel products. It owns a fleet of vessels that consists of Newcastlemax, Capesize, Post Panamax, Kamsarmax, Panamax, Ultramax, and Supramax. It generates revenues through the voyages it carries out.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.